Metabolomics in exploratory toxicology: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol)

Jonathan McDunn, PhD., Associate Director, Diagnostics Research and Development at Metabolomic Inc. and Adjunct Associate Professor of Biomedical Engineering, UNC-Chapel Hill

When Feb 20, 2013 from 02:00 PM to 03:00 PM (US/Eastern / UTC-500)
Where G-605 Koury
Add event to calendar iCal

Sponsored by the Center for Environmental Health and Susceptibility